Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) Return on Equity (2019 - 2025)

Historic Return on Equity for Nexgel (NXGL) over the last 7 years, with Q3 2025 value amounting to 0.52%.

  • Nexgel's Return on Equity rose 2800.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.62% for FY2024, which is 1200.0% down from last year.
  • Latest data reveals that Nexgel reported Return on Equity of 0.52% as of Q3 2025, which was up 2800.0% from 0.55% recorded in Q2 2025.
  • In the past 5 years, Nexgel's Return on Equity registered a high of 0.31% during Q3 2023, and its lowest value of 8.89% during Q3 2021.
  • Its 5-year average for Return on Equity is 1.39%, with a median of 0.56% in 2023.
  • The largest annual percentage gain for Nexgel's Return on Equity in the last 5 years was 95900bps (2021), contrasted with its biggest fall of -42400bps (2021).
  • Over the past 5 years, Nexgel's Return on Equity (Quarter) stood at 0.57% in 2021, then rose by 9bps to 0.52% in 2022, then dropped by -8bps to 0.56% in 2023, then fell by -12bps to 0.63% in 2024, then increased by 16bps to 0.52% in 2025.
  • Its Return on Equity stands at 0.52% for Q3 2025, versus 0.55% for Q2 2025 and 0.56% for Q1 2025.